Differential screening of phage-ab libraries by oligonucleotide microarray technology

A novel and efficient tagArray technology was developed that allows rapid identification of antibodies which bind to receptors with a specific expression profile, in the absence of biological information. This method is based on the cloning of a specific, short nucleotide sequence (tag) in the phage...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 3; no. 1; p. e1508
Main Authors Monaci, Paolo, Luzzago, Alessandra, Santini, Claudia, De Pra, Alessandra, Arcuri, Mirko, Magistri, Francesca, Bellini, Alessandro, Ansuini, Helenia, Ambrosio, Maria, Ammendola, Virginia, Bigotti, Maria Giulia, Cirillo, Agostino, Nuzzo, Maurizio, Nasti, Annamaria Assunta, Neuner, Philippe, Orsatti, Laura, Pezzanera, Monica, Sbardellati, Andrea, Silvestre, Giuseppe, Uva, Paolo, Viti, Valentina, Barbato, Gaetano, Colloca, Stefano, Demartis, Anna, De Rinaldis, Emanuele, Giampaoli, Saverio, Lahm, Armin, Palombo, Fabio, Talamo, Fabio, Vitelli, Alessandra, Nicosia, Alfredo, Cortese, Riccardo
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 30.01.2008
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel and efficient tagArray technology was developed that allows rapid identification of antibodies which bind to receptors with a specific expression profile, in the absence of biological information. This method is based on the cloning of a specific, short nucleotide sequence (tag) in the phagemid coding for each phage-displayed antibody fragment (phage-Ab) present in a library. In order to set up and validate the method we identified about 10,000 different phage-Abs binding to receptors expressed in their native form on the cell surface (10 k Membranome collection) and tagged each individual phage-Ab. The frequency of each phage-Ab in a given population can at this point be inferred by measuring the frequency of its associated tag sequence through standard DNA hybridization methods. Using tiny amounts of biological samples we identified phage-Abs binding to receptors preferentially expressed on primary tumor cells rather than on cells obtained from matched normal tissues. These antibodies inhibited cell proliferation in vitro and tumor development in vivo, thus representing therapeutic lead candidates.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Okairòs, Pomezia, Rome, Italy
Conceived and designed the experiments: PM RC. Performed the experiments: VV FP FT AV CS ADP MArcuri FM AB GB SC AD SG HA MAmbrosio VA MB AC MN AAN LO MP GS. Contributed reagents/materials/analysis tools: PU ED ALahm PN AS. Wrote the paper: PM. Other: Planned and supervised the selection of the Membranome collection: AN ALuzzago. Performed selection and characterization Membranome collection: CS ADP MArcuri FM AB. Conceived and implemented the Membranome collection: RC. Characterized binding properties of the selected IgGs: GB. Converted, expressed and purified IgGs: SC. Contributed software tools for tagArray analysis: ED PU. Set up and performed tagArray experiments: MN GS SG. Contributed software tools for tagArray analysis: ALahm. Peformed in vitro and in vivo experiments using tagArray: HA. Converted, expressed and purified IgGs: AAN AC MB VA MAmbrosio. Synthesized oligonucleotides: PN. Set up and performed Ag identification experiments: AD FT LO. Identified tag sequences: AS. Performed in vitro and in vivo experiments using tagArray: AV MP FP VV. Conceived, developed and implemented the tagArray technology: PM.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0001508